In one of the most recent actions against the pushes of “Low-T” testosterone therapy drugs, a couple has filed a lawsuit against drug maker AbbieVie Inc. and Abbot Laboratories Inc., the manufacturers of a drug called AndroGel.
In Freeman v. AbbieVie, Inc., plaintiff alleges he was prescribed the drug to treat a number of symptoms purportedly caused by reduced levels of testosterone. Within several months of taking the drug, plaintiff asserts he started to suffer from a series of severe complications, which included pain and swelling in his groin, foot and leg.
He sought treatment from a primary care physician, who then referred him to the hospital for a full evaluation. Ultimately, he was diagnosed with deep vein thrombosis, a potentially fatal condition that results when a blood clot forms deep in one’s veins, usually in the legs.